Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–6 of 6 results
Advanced filters: Author: Jesse I. Mobbs Clear advanced filters
  • The A3 adenosine receptor is a promising drug target for cancer, inflammation, and glaucoma. Here, authors determine atomic structures of the human A3 receptor, identifying a previously hidden binding pocket that will aid in the development of more effective A3 receptor-targeted medicines.

    • Liudi Zhang
    • Jesse I. Mobbs
    • David M. Thal
    ResearchOpen Access
    Nature Communications
    Volume: 16, P: 1-19
  • The M5 muscarinic acetylcholine receptor represents a promising therapeutic target for neurological disorders. Here, the authors reveal a 2.1 Å cryo-EM structure of the M5 bound to a selective positive allosteric modulator site that enables structure-based drug design.

    • Wessel A. C. Burger
    • Jesse I. Mobbs
    • David M. Thal
    ResearchOpen Access
    Nature Communications
    Volume: 16, P: 1-15
  • The P2X1 receptor is a promising target for the development of a non-hormonal male contraceptive. Here, researchers determined the atomic structure of the P2X1 receptor, revealing opportunities for developing drugs to target this receptor.

    • Felix M. Bennetts
    • Hariprasad Venugopal
    • David M. Thal
    ResearchOpen Access
    Nature Communications
    Volume: 15, P: 1-14
  • The drug Xanomeline is progressing through clinical trials for the treatment of patients with schizophrenia. Here, the authors determine a cryo-EM structure of Xanomeline bound to its primary target revealing a dual binding mode mechanism.

    • Wessel A. C. Burger
    • Vi Pham
    • David M. Thal
    ResearchOpen Access
    Nature Communications
    Volume: 14, P: 1-11
  • HLA-C expression levels correlate with immune responses to pathogens and autoimmunity, and vary in an allele-specific manner across individuals. Here the authors identify factors that drive differential expression of HLA-C allomorphs at the cell surface, and influence the structure of the peptide-binding cleft and diversity of peptides bound by HLA-C molecules.

    • Gurman Kaur
    • Stephanie Gras
    • Lars Fugger
    ResearchOpen Access
    Nature Communications
    Volume: 8, P: 1-12